These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17547563)

  • 21. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
    Margaritis AR; Brown SM; Seed CR; Kiely P; D'Agostino B; Keller AJ
    Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dengue viremia in blood donors from Honduras, Brazil, and Australia.
    Linnen JM; Vinelli E; Sabino EC; Tobler LH; Hyland C; Lee TH; Kolk DP; Broulik AS; Collins CS; Lanciotti RS; Busch MP
    Transfusion; 2008 Jul; 48(7):1355-62. PubMed ID: 18503610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and cost-benefit of implementing pooled screening for HCVAg in small blood bank settings.
    Sarov B; Novack L; Beer N; Safi J; Soliman H; Pliskin JS; Litvak E; Yaari A; Shinar E
    Transfus Med; 2007 Dec; 17(6):479-87. PubMed ID: 17727618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of low HBV-DNA levels by nucleic acid amplification test (NAT) in blood donors.
    Dettori S; Candido A; Kondili LA; Chionne P; Taffon S; Genovese D; Iudicone P; Miceli M; Rapicetta M
    J Infect; 2009 Aug; 59(2):128-33. PubMed ID: 19586663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays.
    Koppelman MH; Rood IG; Fryer JF; Baylis SA; Cuypers HT
    Vox Sang; 2007 Oct; 93(3):208-15. PubMed ID: 17845257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N; Thaikruea L; Thongsawat S; Leetrakool N; Fongsatikul L; Sompan P; Fong YL; Nichols D; Ziermann R; Ness P; Nelson KE
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Procleix Ultrio transcription-mediated amplification vs. serological blood screening in south-western Greece.
    Sgourou A; Karakantza M; Theodori E; Papadimitriou C; Theodorou GL; Davanos N; Thymianou S; Zoumbos NC; Mouzaki A
    Transfus Med; 2008 Apr; 18(2):104-11. PubMed ID: 18399844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood donor screening for parvovirus B19 in Germany and Austria.
    Schmidt M; Themann A; Drexler C; Bayer M; Lanzer G; Menichetti E; Lechner S; Wessin D; Prokoph B; Allain JP; Seifried E; Hourfar MK
    Transfusion; 2007 Oct; 47(10):1775-82. PubMed ID: 17714425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany.
    Schmidt M; Korn K; Nübling CM; Chudy M; Kress J; Horst HA; Geusendam G; Hennig H; Sireis W; Rabenau HF; Doerr HW; Berger A; Hourfar MK; Gubbe K; Karl A; Fickenscher H; Tischer BK; Babiel R; Seifried E; Gürtler L
    Transfusion; 2009 Sep; 49(9):1836-44. PubMed ID: 19453990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current value of serologic test for syphilis as a surrogate marker for blood-borne viral infections among blood donors in the United States.
    Zou S; Notari EP; Fang CT; Stramer SL; Dodd RY
    Transfusion; 2009 Apr; 49(4):655-61. PubMed ID: 19170999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A method for estimating incidence rate of infectious diseases among first-time blood donors.
    Zou S; Fang CT; Dodd RY
    Transfusion; 2008 Sep; 48(9):1827-32. PubMed ID: 18482184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automated calibration of TECAN genesis liquid handling workstation utilizing an online balance and density meter.
    Xie IH; Wang MH; Carpenter R; Wu HY
    Assay Drug Dev Technol; 2004 Feb; 2(1):71-80. PubMed ID: 15090212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the meaning of permanent deferral for blood donors.
    Whittaker S; Carter N; Arnold E; Shehata N; Webert KE; Distefano L; Heddle NM
    Transfusion; 2008 Jan; 48(1):64-72. PubMed ID: 17894793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
    van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
    Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors influencing the quality of medical documentation when a paper-based medical records system is replaced with an electronic medical records system: an Iranian case study.
    Pourasghar F; Malekafzali H; Koch S; Fors U
    Int J Technol Assess Health Care; 2008; 24(4):445-51. PubMed ID: 18828939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
    Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery and analysis of a novel parvovirus B19 Genotype 3 isolate in the United States.
    Rinckel LA; Buno BR; Gierman TM; Lee DC
    Transfusion; 2009 Jul; 49(7):1488-92. PubMed ID: 19389024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation of hepatitis B virus DNA in plasma using a sensitive cost-effective "in-house" real-time PCR assay.
    Daniel HD; Fletcher JG; Chandy GM; Abraham P
    Indian J Med Microbiol; 2009; 27(2):111-5. PubMed ID: 19384032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.